However, under hypoxic conditions, the expression dynamics of TIMP1 exhibit a dual nature: it restricts tumor invasion by inhibiting MMP-9 and reducing extracellular matrix degradation, but simultaneously promotes chemoresistance by activating the integrin β1/FAK signaling pathway. Here, TIMP1 is linked to neoplasm.